-+ 0.00%
-+ 0.00%
-+ 0.00%

PDS BIOTECH ANNOUNCES POSITIVE EXTENDED FOLLOW-UP DATA FOR VERSATILE-002 AND ADDITIONAL TRIALS EVALUATING VERSAMUNE® HPV TO BE PRESENTED AT THE 2025 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING

Reuters·05/22/2025 21:26:36

Please log in to view news